A synchronization modulation electric field (SMEF) applied during ischemia reduced short-term markers of renal dysfunction in this porcine model. Investigators performed 90 minutes of bilateral renal pedicle occlusion followed by 4 hours of reperfusion in female Yorkshire pigs, assigning animals to sham, injury, or injury plus SMEF (n = 4 per group). Serum creatinine was lower in treated animals (1.85 ± 0.29 versus 2.33 ± 0.17 mg/dl, P = 0.014). Blood urea nitrogen and plasma NGAL fell with treatment; NGAL was 25.8 ± 10.7 ng/ml with SMEF versus 69.9 ± 23.8 ng/ml in injury alone (P = 0.005). The study team also reported reduced cystatin C (P = 0.0016). The data set concentrates on the immediate reperfusion interval; the source did not report longer-term renal function outcomes.
Every treated animal showed lower tubular injury scores (1.31 ± 0.31 versus 3.00 ± 0.00). The cohort showed less cleaved caspase-3 protein after SMEF (P = 0.0094), indicating reduced apoptosis in the early reperfusion window. These tissue-level signals ran consistently with the serum and plasma biomarker improvements. The authors graded tubular injury histologically; specific scoring criteria and inter-rater reproducibility details were not provided in the source.
Kidney RNA sequencing identified 304 genes differing with treatment; most of those genes fell in expression with SMEF. The hallmark gene set TNFA_SIGNALING_VIA_NFKB showed the largest suppression (NES -2.57, FDR 5.0 x 10^-9). Activity estimates for transcriptional regulators — including NF-kappaB, AP-1, STAT3, ATF4 and HSF1 — moved in the opposite direction to the injury pattern, according to the study team. The authors presented these changes as consistent with downregulation of stress-response and inflammatory pathways at the transcript level during the acute reperfusion interval.
Canonical leukocyte marker expression did not differ significantly between groups (PTPRC padj 0.66), and no cellular infiltrate was observed histologically. Recruitment-associated transcripts declined markedly: CCL2 showed a log2 fold change of -2.31 (padj 1.9 x 10^-11), and SELP was also reduced (log2 fold -1.48, padj 9.5 x 10^-4). Tissue CCL2 protein was 24% lower in treated kidneys (P = 0.0062). Taken together, the profile suggests reduced recruitment signaling without measurable leukocyte accumulation in the 4-hour reperfusion window; the authors noted this pattern could indicate an epithelial source for the suppressed inflammatory program.
Despite functional protection, investigators did not observe restoration of Na+/K+-ATPase or mitochondrial transcripts in treated kidneys. Measurements of electron transport chain protein and mitochondrial DNA copy number did not differ significantly between groups. Those null findings led the authors to conclude that SMEF-associated protection is not mediated by transcriptional recovery of the pump or mitochondrial biogenesis within the sampled interval.
Treatment preserved tissue glutathione: 21.43 ± 0.32 nmol/mg protein with SMEF versus 15.76 ± 1.58 nmol/mg protein with injury alone (P = 0.010). The authors estimated that oxidation accounted for only 17% of the glutathione loss seen with injury, implying that preservation of reduced glutathione may be part of the protective phenotype. The source did not provide mechanistic assays that directly link glutathione preservation to specific molecular targets of the field.
Data indicated that protection by SMEF in this porcine model was accompanied by suppression of a stress and inflammatory transcriptional program, without detectable leukocyte accumulation, and without restoration of pump or mitochondrial transcripts. The study team interpreted those results as consistent with an intervention that acts on the function of existing molecules rather than by driving new expression. The authors noted an epithelial origin for the suppressed inflammatory signals based on the absence of infiltrating immune cells and on the drop in recruitment mediators.
The experiment focused on an acute 4-hour reperfusion interval after 90 minutes of ischemia; the source did not report longer-term functional outcomes or safety endpoints beyond that window. Parameters of the applied field (for example, waveform specifics, amplitude ranges, or dose–response relationships) were not detailed in the abstract and are not reported in this source summary. The authors did not find restoration of Na+/K+-ATPase or mitochondrial transcripts, but they did not provide mechanistic biochemical evidence pinpointing the molecular target(s) through which SMEF preserves function. The absence of leukocyte accumulation was documented in this early reperfusion period; whether immune cell dynamics change at later time points was not assessed in the reported data. These gaps define the primary unanswered questions and potential next steps for translation and for mechanistic follow-up.